Dr Catherine Robilio Womack, MD | |
57 Germantown Ct, Suite 100, Cordova, TN 38018-7273 | |
(901) 758-7888 | |
(901) 266-6445 |
Full Name | Dr Catherine Robilio Womack |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 29 Years |
Location | 57 Germantown Ct, Cordova, Tennessee |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336106368 | NPI | - | NPPES |
Q002428 | Medicaid | TN | |
138874001 | Medicaid | AR | |
4355721 | Other | TN | BCBS |
P01294153 | Other | TN | RAILROAD MEDICARE |
00119457 | Medicaid | MS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 30211 (Tennessee) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Baptist Memorial Hospital | Memphis, TN | Hospital |
Methodist Healthcare Memphis Hospitals | Memphis, TN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Baptist Memorial Medical Group, Inc. | 5193610228 | 433 |
News Archive
Scientists at the Gladstone Institutes have defined for the first time a key underlying process implicated in multiple sclerosis (MS)-a disease that causes progressive and irreversible damage to nerve cells in the brain and spinal cord. This discovery offers new hope for the millions who suffer from this debilitating disease for which there is no cure.
Brain cells recorded as among the least electrically active during a specific task may be the most important to doing it right.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that emerging agents from Metabolex/Johnson & Johnson, Merck, Novartis, and Amylin/Eli Lilly are among the most promising drugs in development for metabolic syndrome.
Top-line data from the 270-patient global Phase 2/3 COVID-19 study expected Q1/2021. Top-line data from the 40-patient U.S. Phase 2 study of opaganib in severe COVID-19 expected in the coming days; this non-powered study was designed to evaluate safety and potential identification of preliminary efficacy signals in support of the global Phase 2/3 study of opaganib.
› Verified 6 days ago
Entity Name | Baptist Memorial Medical Group, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1306089206 PECOS PAC ID: 5193610228 Enrollment ID: O20040218000385 |
News Archive
Scientists at the Gladstone Institutes have defined for the first time a key underlying process implicated in multiple sclerosis (MS)-a disease that causes progressive and irreversible damage to nerve cells in the brain and spinal cord. This discovery offers new hope for the millions who suffer from this debilitating disease for which there is no cure.
Brain cells recorded as among the least electrically active during a specific task may be the most important to doing it right.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that emerging agents from Metabolex/Johnson & Johnson, Merck, Novartis, and Amylin/Eli Lilly are among the most promising drugs in development for metabolic syndrome.
Top-line data from the 270-patient global Phase 2/3 COVID-19 study expected Q1/2021. Top-line data from the 40-patient U.S. Phase 2 study of opaganib in severe COVID-19 expected in the coming days; this non-powered study was designed to evaluate safety and potential identification of preliminary efficacy signals in support of the global Phase 2/3 study of opaganib.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Catherine Robilio Womack, MD Po Box 1000, Dept # 457, Memphis, TN 38148-0001 Ph: (901) 758-7888 | Dr Catherine Robilio Womack, MD 57 Germantown Ct, Suite 100, Cordova, TN 38018-7273 Ph: (901) 758-7888 |
News Archive
Scientists at the Gladstone Institutes have defined for the first time a key underlying process implicated in multiple sclerosis (MS)-a disease that causes progressive and irreversible damage to nerve cells in the brain and spinal cord. This discovery offers new hope for the millions who suffer from this debilitating disease for which there is no cure.
Brain cells recorded as among the least electrically active during a specific task may be the most important to doing it right.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that emerging agents from Metabolex/Johnson & Johnson, Merck, Novartis, and Amylin/Eli Lilly are among the most promising drugs in development for metabolic syndrome.
Top-line data from the 270-patient global Phase 2/3 COVID-19 study expected Q1/2021. Top-line data from the 40-patient U.S. Phase 2 study of opaganib in severe COVID-19 expected in the coming days; this non-powered study was designed to evaluate safety and potential identification of preliminary efficacy signals in support of the global Phase 2/3 study of opaganib.
› Verified 6 days ago
Dr. Gary David Strasberg, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2551 Ashburton Pl N, Cordova, TN 38016 Phone: 901-275-4922 | |
Gregory K Jenkins, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8138 Country Village Dr, Cordova, TN 38016 Phone: 901-260-3100 Fax: 901-755-1113 | |
Dr. Catherine Mulroy Munn, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8138 Country Village Dr, Cordova, TN 38016 Phone: 901-260-3100 Fax: 901-755-1113 | |
Dr. Sandra W Cohen, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 57 Germantown Ct, Suite 100, Cordova, TN 38018 Phone: 901-758-7888 Fax: 901-266-6445 | |
Charles R Arkin, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 540 Trinity Creek Cv, Cordova, TN 38018 Phone: 901-309-5000 Fax: 901-309-5008 | |
Dr. John M Bills Jr., MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1660 Bonnie Ln Ste 105, Cordova, TN 38016 Phone: 901-888-1000 | |
Dr. Frank John Adcock Iii, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 8596 Rockcreek Pkwy, Cordova, TN 38016 Phone: 901-372-4350 Fax: 901-372-4350 |